These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34155011)

  • 1. Bilateral macular drusen in acquired partial lipodystrophy with type 2 membranoproliferative glomerulonephritis.
    Tanner A; Chan HW; Stears A; Moosajee M
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34155011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ocular impairment during type II membranoproliferative glomerulonephritis].
    Lahbil D; Rais L; Hamdani M; El Kettani A; Laouissi N; Zaghloul K; Amraoui A
    J Fr Ophtalmol; 2002 Nov; 25(9):949-54. PubMed ID: 12515943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundus changes in type III membranoproliferative glomerulonephritis: a case report.
    Takei M; Obana A; Inomata T; Tanaka T; Shiang T; Bae Y; Takemura T; Murakami A
    BMC Ophthalmol; 2018 Mar; 18(1):72. PubMed ID: 29510686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-speed ultrahigh-resolution OCT of Bruch's membrane in membranoproliferative glomerulonephritis type 2.
    Adhi M; Read SP; Liu JJ; Fujimoto JG; Duker JS
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):614-7. PubMed ID: 25423645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long history of dense deposit disease.
    Cunningham A; Kotagiri A
    BMC Ophthalmol; 2018 Sep; 18(Suppl 1):228. PubMed ID: 30255792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term fundus changes in acquired partial lipodystrophy.
    Jansen J; Delaere L; Spielberg L; Leys A
    BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24248317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities.
    O'Brien C; Duvall-Young J; Brown M; Short C; Bone M
    Br J Ophthalmol; 1993 Dec; 77(12):778-80. PubMed ID: 8110672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.
    Ulbig MR; Riordan-Eva P; Holz FG; Rees HC; Hamilton PA
    Am J Ophthalmol; 1993 Oct; 116(4):410-3. PubMed ID: 8213970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II].
    Framme C; Herboth T; Roider J; Laqua H
    Klin Monbl Augenheilkd; 1998 Oct; 213(4):252-3. PubMed ID: 9848073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare case of spot diagnosis of nephrotic syndrome in a Saudi male.
    Askar A; Mushtaq F; Al Shuaibi F; Mustafa M; Bappu A
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1003-7. PubMed ID: 21912033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive drusen in type I membranoproliferative glomerulonephritis.
    Han DP; Sievers S
    Arch Ophthalmol; 2009 Apr; 127(4):577-9. PubMed ID: 19365045
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinal manifestations in patients with complement-mediated membranoproliferative glomerulonephritis.
    de-Pablo-Gómez-de-Liaño L; Cañas Zamarra I; Fernández-Vigo JI; Fernández Vidal M; Navarro-Perea C; Cavero Escribano T
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Feb; 94(2):95-99. PubMed ID: 30078750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current knowledge on reticular pseudodrusen in age-related macular degeneration.
    Alten F; Eter N
    Br J Ophthalmol; 2015 Jun; 99(6):717-22. PubMed ID: 25232026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drusen in Bruch's membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration].
    Pauleikhoff D
    Ophthalmologe; 1992 Oct; 89(5):363-86. PubMed ID: 1304217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lectin binding of drusen, RPE, Bruch's membrane, and photoreceptors.
    D'Souza YB; Jones CJ; Bonshek RE
    Mol Vis; 2009; 15():906-11. PubMed ID: 19421409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease").
    Colville D; Guymer R; Sinclair RA; Savige J
    Am J Kidney Dis; 2003 Aug; 42(2):E2-5. PubMed ID: 12900843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal findings in membranoproliferative glomerulonephritis.
    Mansour AM; Lima LH; Arevalo JF; Amaro MH; Lozano V; Ghannam AB; Chan EW
    Am J Ophthalmol Case Rep; 2017 Sep; 7():83-90. PubMed ID: 29260086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal disease in the C3 glomerulopathies and the risk of impaired vision.
    Savige J; Amos L; Ierino F; Mack HG; Symons RC; Hughes P; Nicholls K; Colville D
    Ophthalmic Genet; 2016 Dec; 37(4):369-376. PubMed ID: 26915021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microperimetric evaluation of macula in retinopathy of membranoproliferative glomerulonephritis type II: a case report.
    Shenoy R; McCilvenny S
    Eur J Ophthalmol; 2006; 16(4):634-6. PubMed ID: 16952110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series.
    Dalvin LA; Fervenza FC; Sethi S; Pulido JS
    Ophthalmology; 2016 Jul; 123(7):1588-94. PubMed ID: 26996341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.